A recent joint clinical study conducted by Samsung and Chung-Ang University Gwangmyeong Hospital in South Korea has demonstrated that biosignals obtained from a commercial smartwatch can accurately predict vasovagal syncope (VVS).
Understanding Vasovagal Syncope
Vasovagal syncope is a condition characterized by an abrupt drop in heart rate and blood pressure, frequently triggered by factors such as excessive stress. This sudden physiological change leads to a temporary loss of consciousness. While the fainting spells themselves are typically not life-threatening, the resulting sudden falls pose a significant risk for severe secondary injuries, including concussions and fractures. Because of these risks, the ability to predict episodes before they occur is considered critical for patient safety and injury prevention.
Study Methodology and Results
The clinical research team, led by Professor Cho, evaluated 132 patients presenting with suspected VVS symptoms. The evaluations took place during induced fainting tests. Throughout the tests, patients were monitored using a Samsung Galaxy Watch6 equipped with a photoplethysmography (PPG) sensor.
Researchers applied an artificial intelligence algorithm to analyze the heart rate variability (HRV) data collected by the watch. The study yielded the following predictive results:
- Advance Warning: The model successfully predicted impending fainting episodes up to five minutes in advance.
- Overall Accuracy: 84.6%
- Sensitivity: 90%
- Specificity: 64%
These findings indicate a clinically meaningful level of predictive capability. The research, which has been published in Volume 7, Issue 4 of the European Heart Journal – Digital Health, marks the first study globally to successfully demonstrate the potential for a commercial smartwatch to provide early prediction of syncope.
Future Implications for Wearable Health Technology
Following the publication of these results, Samsung has outlined plans to continue advancing the health monitoring capabilities across its portfolio of wearable devices. The company intends to expand its collaborative efforts with leading medical institutions to further the development of the digital health industry and accelerate the implementation of personalized, preventive healthcare solutions.
Professor Junhwan Cho of the Department of Cardiology at Chung-Ang University Gwangmyeong Hospital said:
Up to 40% of people experience vasovagal syncope over their lifetime, with one-third experiencing recurrent episodes. An early warning could give patients advance time to get into a safe position or call for help, which would dramatically reduce the incidence of secondary injuries.
Jongmin Choi, Head of Health R&D Group, Mobile eXperience (MX) Business, Samsung Electronics, said:
This study is an example of how wearable technology can help shift healthcare from being designed for ‘post-care’ to a model of ‘preventive care. We are committed to driving technological innovation that empowers our users to lead healthier everyday lives.